Search Results
Slidesets
VBI-2601 Immunotherapeutic HBV Vaccine Candidate Overview - F. Diaz-Mitoma, MD, PhD
Presented at:
International Workshop on HBV Cure 2021
Abstracts
Results from two phase-3 double-blind, randomized, controlled trials, PROTECT and CONSTANT, evaluating immunogenicity and safety of the 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared to the single-antigen vaccine, Engerix ® in adults
F. Diaz-Mitoma
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Â
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Slidesets
Plenary Lecture: Opportunities and Challenges for a Broadly Protective Influenza Vaccine | Gary Nabel, MD
Presented at:
RespiDART 2018
Abstracts
Decreased Hepatitis B Vaccine Efficacy in Obese Individuals and Approaches to Previously Immunized Non-Responders
Presented at:
Conference on Liver Disease in Africa (COLDA) 2019
Slidesets
Fast-tracking vaccines for epidemic diseases: An update from CEPI- Richard Hatchett, MD
Presented at:
International Conference on (Re-) Emerging Infectious Diseases (ICREID) 2018
Slidesets
Determinants of the Onset and Prognosis of the Post-COVID-19 Condition - R. Paredes, MD, PhD.pdf
Presented at:
Viral Infections & Inflammation Workshop 2023
Abstracts
Prevalence of undiagnosed HBV infection in patients with COVID-19
V. Miron
Reviews in Antiviral Therapy & Infectious Diseases 10, 2021
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Abstracts
Evaluation of hepatitis B vaccine efficacy among healthcare worker at Laquintinie Hospital, Douala, Cameroon.
R. Kamga Wouambo
Reviews in Antiviral Therapy & Infectious Diseases 11, 2020
Presented at:
International Viral Hepatitis Elimination Meeting (IVHEM) 2020
Abstracts
Immunogenicity of single dose of hepatitis A vaccine (Havrix) in HIV-positive individuals: a retrospective cohort
T. Hung
Reviews in Antiviral Therapy & Infectious Diseases 6, 2020
Presented at:
APACC 2020
Slidesets
Adaptive Immunity: Therapeutic vaccination, checkpoint inhibition and potential others- Andre Boonstra, PhD
Presented at:
International Workshop on HBV Cure 2017